تيد إم. داوسون
Dawson, Ted Murray.
Dawson, Ted M.
Dawson, Ted Murray 1959-
VIAF ID: 272943325 (Personal)
Permalink: http://viaf.org/viaf/272943325
Preferred Forms
- 100 1 _ ‡a Dawson, Ted M.
-
- 100 1 _ ‡a Dawson, Ted Murray
- 100 1 _ ‡a Dawson, Ted Murray
- 100 1 _ ‡a Dawson, Ted Murray ‡d 1959-
-
-
- 100 0 _ ‡a تيد إم. داوسون
4xx's: Alternate Name Forms (6)
Works
Title | Sources |
---|---|
Localization and characterization ... 1986 | |
Molecular mechanisms of cell death: recommendations of the Nomenclature Committee on Cell Death 2018. | |
Motor neuron death in ALS: programmed by astrocytes? | |
Msp1/ATAD1 maintains mitochondrial function by facilitating the degradation of mislocalized tail-anchored proteins | |
Neurodegeneration | |
Neuronal activity regulates hippocampal miRNA expression | |
Neuronal NOS and cyclooxygenase-2 contribute to DNA damage in a mouse model of Parkinson disease | |
Neuroprotection by pharmacologic blockade of the GAPDH death cascade | |
Neuroprotective and neurorestorative strategies for Parkinson's disease | |
Neurotoxic reactive astrocytes are induced by activated microglia | |
Neurotoxicity and behavioral deficits associated with Septin 5 accumulation in dopaminergic neurons | |
New insights into Parkinson?s disease | |
Next-generation sequencing reveals substantial genetic contribution to dementia with Lewy bodies | |
The NINDS Parkinson's disease biomarkers program | |
Nitric oxide-induced nuclear GAPDH activates p300/CBP and mediates apoptosis | |
NMDA-induced neuronal survival is mediated through nuclear factor I-A in mice | |
Novel monoclonal antibodies demonstrate biochemical variation of brain parkin with age. | |
Nuclear and mitochondrial conversations in cell death: PARP-1 and AIF signaling | |
Nuclear localization of a non-caspase truncation product of atrophin-1, with an expanded polyglutamine repeat, increases cellular toxicity | |
A nuclease that mediates cell death induced by DNA damage and poly(ADP-ribose) polymerase-1 | |
Opportunities for the repurposing of PARP inhibitors for the therapy of non-oncological diseases | |
The orphan nuclear receptor, steroidogenic factor 1, regulates neuronal nitric oxide synthase gene expression in pituitary gonadotropes | |
Outer mitochondrial membrane localization of apoptosis-inducing factor: mechanistic implications for release | |
PARK10 is a major locus for sporadic neuropathologically confirmed Parkinson disease | |
Parkin and Hsp70 sacked by BAG5. | |
Parkin and PINK1: much more than mitophagy | |
Parkin blushed by PINK1. | |
Parkin-independent mitophagy requires Drp1 and maintains the integrity of mammalian heart and brain | |
Parkin loss leads to PARIS-dependent declines in mitochondrial mass and respiration | |
Parkin-mediated lysine 63-linked polyubiquitination: a link to protein inclusions formation in Parkinson's and other conformational diseases? | |
Parkin mediates the degradation-independent ubiquitination of Hsp70 | |
Parkinson's disease-associated mutations in LRRK2 link enhanced GTP-binding and kinase activities to neuronal toxicity | |
Parkinson's disease : genetics and pathogenesis | |
PARP-1 gene disruption in mice preferentially protects males from perinatal brain injury. | |
Parthanatos mediates AIMP2-activated age-dependent dopaminergic neuronal loss | |
Parthanatos: mitochondrial-linked mechanisms and therapeutic opportunities | |
Pathological α-synuclein transmission initiated by binding lymphocyte-activation gene 3, (College of Medicine | |
Phosphorylation by the c-Abl protein tyrosine kinase inhibits parkin's ubiquitination and protective function | |
PINK1-dependent recruitment of Parkin to mitochondria in mitophagy | |
The PINK1 p.I368N mutation affects protein stability and ubiquitin kinase activity | |
Poly(ADP-ribose) polymerase-1 and apoptosis inducing factor in neurotoxicity | |
Poly(ADP-ribose) polymerase-dependent energy depletion occurs through inhibition of glycolysis | |
Poly(ADP-ribose) polymerase impairs early and long-term experimental stroke recovery | |
Poly(ADP-ribose) signals to mitochondrial AIF: a key event in parthanatos | |
Precision therapy for a new disorder of AMPA receptor recycling due to mutations in ATAD1. | |
Proteome-wide identification of poly(ADP-ribose) binding proteins and poly(ADP-ribose)-associated protein complexes | |
Reevaluation of phosphorylation sites in the Parkinson disease-associated leucine-rich repeat kinase 2 | |
Reply: Heterozygous PINK1 p.G411S in rapid eye movement sleep behaviour disorder. | |
Reprogramming cellular events by poly(ADP-ribose)-binding proteins | |
Resistance to MPTP-neurotoxicity in α-synuclein knockout mice is complemented by human α-synuclein and associated with increased β-synuclein and Akt activation | |
Revelations and revolutions in the understanding of Parkinson's disease. | |
The road to survival goes through PARG. | |
The role of parkin in familial and sporadic Parkinson's disease | |
S-nitrosylation of XIAP compromises neuronal survival in Parkinson's disease | |
en scientific article | |
Sex differences in progression to mild cognitive impairment and dementia in Parkinson's disease. | |
Stress-induced alterations in parkin solubility promote parkin aggregation and compromise parkin's protective function | |
Sulfhydration mediates neuroprotective actions of parkin | |
Tabibi Sabbu | |
Transcriptional responses to loss or gain of function of the leucine-rich repeat kinase 2 (LRRK2) gene uncover biological processes modulated by LRRK2 activity | |
TRPV1 on astrocytes rescues nigral dopamine neurons in Parkinson's disease via CNTF. | |
Ubiqutination via K27 and K29 chains signals aggregation and neuronal protection of LRRK2 by WSB1. | |
Unexpected lack of hypersensitivity in LRRK2 knock-out mice to MPTP (1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine). | |
Usp16: key controller of stem cells in Down syndrome | |
What causes cell death in Parkinson's disease? | |
What have genetically engineered mice taught us about ischemic injury? |